Transform drug development with high impact data products
Achieve fast, FDA-compliant data product creation and management with Lifebit’s powerful software to harmonize, organize, and catalog biomedical data in your own environment.
Trusted by the world's biomedical leaders
INACCESSIBLE DATA
10-18 months
To locate and access data as 80% of health data is unavailable for R&D
UNUSABLE DATA
6-18 months
To turn raw data into usable data ready for research
SLOW RESULTS
5-7 years
Average time to target identification and validation
NON COMPLIANT DATA SHARING
3 in 4
Pharma companies are not fully compliant with US data guidelines
Pharma Data Challenges
THE FOUNDATION FOR SUCCESS: SECURE, EFFICIENT, AND COMPLIANT DATA MANAGEMENT
Rapid Data Product Creation & Management
Lifebit’s Trusted Data Lakehouse™ is trusted by top pharma and data providers for creating data products at scale across a global data network with over 250M patients.
Lifebit’s Trusted Data Lakehouse™ is the industry’s only solution specifically designed for multimodal biomedical data. Featuring cutting-edge proprietary AI automation, it seamlessly fetches, connects, harmonizes data to OMOP standards, and catalogs health-omic data, enabling users to efficiently build data products. Lifebit has proven efficiencies across a global data network with over 250M patients.
Fully Compliant with FDA RWE Requirements
Lifebit’s Trusted Data Lakehouse™ is the only lakehouse to meet stringent FDA real-world evidence (RWE) guidelines, offering complete audit trails, data lineage and provenance with each retrieval.
As the preferred partner of governments, Lifebit Trusted Data Lakehouse™ solution goes above and beyond enforcing FDA standards to further ensure data residency, 5-Safes, FedRAMP, GDPR, HIPAA, ISO, and SOC II compliance, among others.
Only Lakehouse to seamlessly fetch EHR & NGS data
Lifebit’s Trusted Data Lakehouse™ uniquely connects to major EHR systems, including Epic, Cerner, and MedTech, as well as leading NGS providers and on-site sequencing facilities.
Lifebit’s Trusted Data Lakehouse™ enables compliant access to distributed clinical and genomic data across extensive U.S. and global healthcare networks, enabling flexible data retrieval for comprehensive analysis in one unified environment.
Save Costs, Maximize Efficiency
Lifebit’s Al-powered, self-serve platform reduces costs through automated data harmonization, leveraging your existing cloud infrastructure and preventing redundant data purchases.
Lifebit’s Trusted Data Lakehouse™ automates data cleaning, mapping, and standardization, saving time and minimizing errors. Advanced data QA, cohort browsing, and interactive tools further streamline processes and effective data cataloging prevents redundant data purchases. All in your own secure cloud environment, avoiding excessive cloud fees.
Your data. Fully FDA compliant. Accelerating discovery and translation.
Lifebit’s Trusted Data Lakehouse™ enables pharmaceutical companies to efficiently create and manage FDA-compliant data products to power successful target identification & translation, RWE studies, clinical trials, medical affairs, HEOR and market access.
Trusted Data Lakehouse™ (TDL)
Create and manage your health data products
Fetch, connect, harmonize, and catalog clinico-genomic data seamlessly—all in one secure platform to power your data products.
MEET LIFEBIT’S FEDERATED & TRUSTED DATA LAKEHOUSE™
Meet the pioneers.
Abbvie uses Lifebit’s platform to advance the search for new treatments for common chronic illnesses through population genomics research.
Ionis Pharmaceuticals use the Lifebit platform and a combination of deep phenotypic data and high-quality whole-genome sequencing to improve the understanding of fundamental disease mechanisms. This strategy has the potential to greatly accelerate the drug development process by translating targets into therapies faster.
J&J uses Lifebit’s platform to seek to understand differences in patient responses in autoimmune disorders to make it easier to target more specific patient subpopulations that could lead to the development of new treatment drugs.
The Lifebit platform empowers GSK to assess variability among patients with conditions including heart failure and liver disease and gain a deeper understanding of illness severity and symptoms. It is intended to make it easier to identify more focused patient subgroups, which could potentially allow for the advancement of particular therapeutic medicines in particular patient subgroups.
“This platform will play an important part of Boehringer Ingelheim’s broader strategy to capture translational disease insights from large external healthcare biobanks and ultimately to accelerate the development of innovative medicines.”
Dr. Jan Nygaard Jensen
SVP & Global Head of Computational Biology & Digital Sciences
Creating successful data products
Lifebit partners with Boehringer Ingelheim to capture insights from large external healthcare biobanks, accelerating the development of innovative medicines.
Customer Story: Boehringer Ingelheim
Ready to maximize the value of your data?
Contact Lifebit today and discover how our federated solutions can power your data.
We’ll respond as soon as possible.
